On February 26, 2020, DEA issued a proposed rule titled Registration Requirements for Narcotic Treatment Programs with Mobile Components. The proposed rule would waive the requirement of a separate registration for opioid treatment programs (OTPs) that utilize a mobile component. The Controlled Substances Act (CSA) generally requires, with certain exceptions, all persons who dispense controlled […]
Michael Barnes, JD recently made an appearance on Fox Business Live, where he discussed conflicting messages about the impact of the U.S. drug abuse crisis on corporate profits. Mr. Barnes then analyzed drug pricing bills in Congress and how they could affect Americans’ access to new medicines for conditions like Alzheimer’s and cancer. The original […]
Michael C. Barnes, JD authored an article published this week in PAINWeek Journal entitled “I’m Not a Doctor, But I Play One in D.C.: Federal Action and Its Impact on Care.” Mr. Barnes’s article discusses the unintended consequences of state and federal opioid policy. The article analyzes changing trends in Washington, state capitals, and courthouses […]
Today, American University’s Washington College of Law published in its Legislation & Policy Brief a new article by Michael C. Barnes, JD. Entitled “A More Sensible Surge: Ending DOJ’s Indiscriminate Raids of Health Care Providers,” the article discusses the indiscriminate nature of recent U.S. Department of Justice (DOJ) raids, searches, and investigations of prescribers of […]